Literature DB >> 16893507

Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip.

Victor A Rosenberg1, Gary S Eglinton, Eden R Rauch, Daniel W Skupski.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether continuous insulin infusion provides a greater degree of intrapartum maternal glycemic control than rotating between glucose and non-glucose containing intravenous fluids. STUDY
DESIGN: Laboring patients with pregestational or gestational diabetes were recruited and randomized to an "insulin drip" or "rotating fluids" protocol. The primary outcome measure was mean maternal capillary blood glucose (CBG) levels (mg/dL). Power analysis indicated that 16 patients were needed in each arm to find a difference of 10 mg/dL.
RESULTS: Fifteen patients were randomized to the rotating fluids protocol and 21 patients to an insulin drip. There was no difference in mean intrapartum maternal CBG levels (103.9 +/- 8.7 mg/dL and 103.2 +/- 17.9 mg/dL in the rotating fluids and insulin drip group, respectively, P = .89). Neonatal outcomes were also similar between the 2 treatment groups.
CONCLUSION: In patients with insulin requiring gestational diabetes, intrapartum glycemic control may be comparable with a standard adjusted insulin drip or a rotation of intravenous fluids between glucose and non-glucose containing fluids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893507     DOI: 10.1016/j.ajog.2006.05.051

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  The peripartum management of diabetes.

Authors:  Y Yap; A Modi; N Lucas
Journal:  BJA Educ       Date:  2019-11-26

Review 2.  Inpatient management of women with gestational and pregestational diabetes in pregnancy.

Authors:  Etoi A Garrison; Shubhada Jagasia
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

3.  Management of Diabetes in the Intrapartum and Postpartum Patient.

Authors:  Annie Dude; Charlotte M Niznik; Emily D Szmuilowicz; Alan M Peaceman; Lynn M Yee
Journal:  Am J Perinatol       Date:  2018-03-13       Impact factor: 1.862

Review 4.  Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy.

Authors:  Laura T Dickens; Celeste C Thomas
Journal:  Curr Diab Rep       Date:  2019-05-09       Impact factor: 4.810

Review 5.  Glucose control during labor and delivery.

Authors:  Edmond A Ryan; Rany Al-Agha
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

6.  Evaluation of an Intrapartum Insulin Regimen for Women With Diabetes.

Authors:  Annie M Dude; Charlotte Niznik; Alan M Peaceman; Lynn M Yee
Journal:  Obstet Gynecol       Date:  2020-08       Impact factor: 7.623

Review 7.  Peripartum management of diabetes.

Authors:  Pramila Kalra; Manjunath Anakal
Journal:  Indian J Endocrinol Metab       Date:  2013-10

8.  A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study.

Authors:  O Kgosidialwa; D Bogdanet; A M Egan; P M O'Shea; C Newman; T P Griffin; C McDonagh; C O'Shea; L Carmody; S D Cooray; E Anastasiou; E Wender-Ozegowska; C Clarson; A Spadola; F Alvarado; E Noctor; E Dempsey; A Napoli; C Crowther; S Galjaard; M R Loeken; Mja Maresh; P Gillespie; H de Valk; A Agostini; L Biesty; D Devane; F Dunne
Journal:  BJOG       Date:  2021-08-03       Impact factor: 7.331

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.